v3.19.1
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Operating Activities:    
Net income $ 207,663 $ 210,910
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, amortization and impairment expense 61,871 51,879
Loss (gain) on sale and retirement of assets (21,759) 1,997
Earnings of non-controlled entities (31,255) (34,538)
Distributions from operations of non-controlled entities 43,069 51,754
Equity-based incentive compensation expense 4,914 6,632
Amortization of prior service credit and actuarial loss 1,303 5,069
Debt prepayment penalty 8,270 0
Changes in operating assets and liabilities:    
Trade accounts receivable and other accounts receivable (36,886) 23,371
Inventory (9,313) (13,642)
Energy commodity derivatives contracts, net of derivatives deposits 7,135 617
Accounts payable 2,909 19,457
Accrued payroll and benefits (39,065) (26,544)
Accrued interest payable (16,470) (17,956)
Accrued taxes other than income (12,020) (16,721)
Accrued product liabilities 18,949 (10,893)
Deferred revenue (2,395) 1,463
Current and noncurrent environmental liabilities (1,947) (359)
Other current and noncurrent assets and liabilities 21,583 25,406
Net cash provided by operating activities 206,556 277,902
Investing Activities:    
Additions to property, plant and equipment, net (206,436) (99,471)
Proceeds from sale and disposition of assets 53,676 214
Investments in non-controlled entities (76,634) (60,976)
Distributions from returns of investments in non-controlled entities 7,500 0
Net cash used by investing activities (221,894) (160,233)
Financing Activities:    
Distributions paid (227,832) (209,940)
Net commercial paper borrowings 69,000 0
Borrowings under long-term notes 496,855 0
Payments on notes (550,000) 0
Debt placement costs (5,355) (315)
Net payment on financial derivatives (8,028) 0
Payments associated with settlement of equity-based incentive compensation (9,764) (9,285)
Debt prepayment penalty (8,270) 0
Net cash used by financing activities (243,394) (219,540)
Change in cash, cash equivalents and restricted cash (258,732) (101,871)
Cash, cash equivalents and restricted cash at beginning of period 309,261 176,068
Cash, cash equivalents and restricted cash at end of period 50,529 74,197
Supplemental non-cash investing and financing activities:    
Issuance of limited partner units in settlement of equity-based incentive plan awards 480 120
Additions to property, plant and equipment (260,734) (105,384)
Changes in accounts payable and other current liabilities related to capital expenditures 54,298 5,913
Additions to property, plant and equipment, net $ (206,436) $ (99,471)